Farglitazar

DB19311InvestigationalSmall molecule

Farglitazar: Overview.

Chemical structure of Farglitazar
Mechanism
Curator reviewed
Formula / weight
C34H30N2O5 · 546.623 g/mol (avg)
Also known as
L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)- · N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE
Code names
G1-262570 · GI262570 · GI-262570X

Resolves to

Compound
UNII3433GY7132CAS274687-78-4ChEMBLCHEMBL107367
Structure
InChIKeyZZCHHVUQYRMYLW-HKBQPEDESA-NSMILESCC1=C(CCOC2=CC=C(C[C@H](NC3=CC=CC=C3C(=O)C3=CC=CC=C3)C(O)=O)C=C2)N=C(O1)C1=CC=CC=C1
Targets
P37231PPARG

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Farglitazar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In